NIH-Sponsored Trial of Enterovirus D68 Therapeutic Begins
June 28, 2024
June 28, 2024
WASHINGTON, June 28 (TNSres) -- The U.S. Department of Health and Human Services' National Institutes of Health issued the following news release on June 27, 2024:
* * *
Monoclonal antibody developed from blood of recovering patients.
* * *
The National Institutes of Health (NIH) is sponsoring a clinical trial to evaluate the safety of an investigational monoclonal antibody to treat enterovirus D68 (EV-D68), which can cause severe respiratory a . . .
* * *
Monoclonal antibody developed from blood of recovering patients.
* * *
The National Institutes of Health (NIH) is sponsoring a clinical trial to evaluate the safety of an investigational monoclonal antibody to treat enterovirus D68 (EV-D68), which can cause severe respiratory a . . .